2 not yet recruiting, 2 recruiting. 3 Phase 2, 1 Not applicable, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Recruiting 2, Not yet recruiting 1 |
| Not applicable | 1 | Not yet recruiting 1 |
| Phase 1 | 1 | Recruiting 1 |
Follow Neoadjuvant Chemo-Immunotherapy: new trials by email Literature Review of Neoadjuvant Chemo-Immunotherapy trials Research Report on Neoadjuvant Chemo-Immunotherapy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Neoadjuvant Docetaxel, Cisplatin, and Dual Immunotherapy for Sinonasal Carcinoma Neoadjuvant Chemo-Immunotherapy - Locally Advanced Sinonasal Carcinoma | Phase 2 | Not yet recruiting | Sun Yat-sen University | 23 | 2026-07-31 | 2026-06-25 |
| Pucotenlimab Combined With Chemotherapy as Perioperative Treatment for Locally Advanced Gastroesophageal Junction Carcinoma Neoadjuvant chemo-immunotherapy - Gastroesophageal Junction, Gastric / Gastroesophageal Junction Adenocarcinoma | Not applicable | Not yet recruiting | Tang-Du Hospital | 30 | 2025-08-01 | 2025-07-29 |
| NEoadjuvant Chemotherapy and Immunotherapy for a Selected Group of Inoperable Pleural Mesothelioma Patients (NECIM): a Feasibility Study Neoadjuvant chemo-immunotherapy, Extended pleurectomy/decortication in case of reaching operability - Pleural Epithelioid Mesothelioma, Mesothelioma; Pleura | Phase 1 / Phase 2 | Recruiting | University Hospital, Antwerp | 37 | 2025-07-22 | 2025-08-13 |
| Study of Tislelizumab for Locally Advanced Non-Small Cell Lung Cancer Following Neoadjuvant Chemotherapy Plus Tislelizumab ± Bevacizumab and Definitive Concurrent Chemoradiation Therapy Neoadjuvant chemo-immunotherapy, Bevacizumab, Radiotherapy - Stage III Non-small Cell Lung Cancer | Phase 2 | Recruiting | Sun Yat-sen University | 116 | 2022-01-01 | 2024-10-30 |
Carcinoma, Non-Small-Cell Lung (1) · Mesothelioma, Malignant (1)
Sun Yat-sen University (2) · Tang-Du Hospital (1) · University Hospital, Antwerp (1)
Belgium (1) · China (1)
Chunyan Chen (1) · Hui Liu (1) · Xuekui Liu (1)
PMID 20980108, PMID 28885881, PMID 29658848, PMID 32424483, PMID 32979984, PMID 32997907
2023 (1)